Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Institutions of which they are part Head of group Neurodegenerative Diseases Vall Hebron Institut de Recerca Email Miquel Vila Bover Email Institutions of which they are part Head of group Neurodegenerative Diseases Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Projects Rol de la neuromelanina y alfa-sinucleína en el inicio y extensión de la Enfermedad de Parkinson: potencial diagnóstico y terapéutico en nuevos modelos pre-clínicos IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 82400 Reference: FI14/00613 Duration: 01/01/2015 - 31/12/2018 Disfunción mitocondrial en la enfermedad de Parkinson: papel de la dinámica mitocondrial IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: Ministerio de Educación, Cultura y Deporte Funding: 61544 Reference: FPU13/01339 Duration: 02/09/2014 - 31/01/2018 Prion-like Dissemination of Synuclein Pathology: A Non-human Study IP: Miquel Vila Bover Collaborators: - Funding agency: Michael J. Fox Foundation Funding: 374375 Reference: PRIONLIKE_MJFF2013 Duration: 01/01/2014 - 31/12/2016 Transcriptional profiling by Next-Generation Sequencing in pre-symptomatic, early and advanced phases of Parkinson's Disease IP: Miquel Vila Bover Collaborators: Ariadna Laguna Tuset, Laia Perez Lasarte Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 91022.4 Reference: 2013 BP_B 00113 Duration: 01/10/2014 - 30/09/2016 Pagination First page « Previous page ‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 … Next page › Last page »
